Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Ding

Showing results (651-660 of 736) with videos related to

Pageof 74
Sort By:
Frontiers in Cardiovascular Medicine|December 30, 2022
Contactless multiscale measurement of cardiac motion using biomedical radar sensorJia-Hao Qiao, Fu-Gui Qi, Fu-Lai Liang, et al.
Journal of Medicinal Chemistry|April 30, 2024
Discovery of LLC0424 as a Potent and Selective <i>in Vivo</i> NSD2 PROTAC DegraderLianchao Liu, Abhijit Parolia, Yihan Liu, et al.
Journal of Medicinal Chemistry|June 8, 2007
Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteinsGuozhi Tang, Ke Ding, Zaneta Nikolovska-Coleska, et al.
BMC Anesthesiology|August 23, 2023
The relationship between longer leukocyte telomeres and dNCR in non-cardiac surgery patients: a retrospective analysisChen Liu, Ke Ding, Mannan Abdul, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 InhibitorsWuqing Deng, Xiaojuan Chen, Kaili Jiang, et al.
Pediatric Cardiology|November 9, 2014
A novel NKX2.6 mutation associated with congenital ventricular septal defectJuan Wang, Jian-Hui Mao, Ke-Ke Ding, et al.
Frontiers in Pharmacology|January 2, 2023
ASK120067 potently suppresses B-cell or T-cell malignancies <i>in vitro</i> and <i>in vivo</i> by inhibiting BTK and ITKPeiran Song, Gang Bai, Shingpan Chan, et al.
European Journal of Medicinal Chemistry|February 16, 2018
Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancerQiuping Xiang, Chao Wang, Yan Zhang, et al.
Zoological Research|August 22, 2022
Coevolutionary insights between promoters and transcription factors in the plant and animal kingdomsJing-Song Zhang, Hai-Quan Wang, Jie Xia, et al.
European Journal of Medicinal Chemistry|May 15, 2018
Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancerXiaoqian Xue, Yan Zhang, Chao Wang, et al.
Pageof 74

Showing results (651-660 of 736) with videos related to

Sort By:
Pageof 74
Frontiers in Cardiovascular Medicine|December 30, 2022
Contactless multiscale measurement of cardiac motion using biomedical radar sensorJia-Hao Qiao, Fu-Gui Qi, Fu-Lai Liang, et al.
Journal of Medicinal Chemistry|April 30, 2024
Discovery of LLC0424 as a Potent and Selective <i>in Vivo</i> NSD2 PROTAC DegraderLianchao Liu, Abhijit Parolia, Yihan Liu, et al.
Journal of Medicinal Chemistry|June 8, 2007
Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteinsGuozhi Tang, Ke Ding, Zaneta Nikolovska-Coleska, et al.
BMC Anesthesiology|August 23, 2023
The relationship between longer leukocyte telomeres and dNCR in non-cardiac surgery patients: a retrospective analysisChen Liu, Ke Ding, Mannan Abdul, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 InhibitorsWuqing Deng, Xiaojuan Chen, Kaili Jiang, et al.
Pediatric Cardiology|November 9, 2014
A novel NKX2.6 mutation associated with congenital ventricular septal defectJuan Wang, Jian-Hui Mao, Ke-Ke Ding, et al.
Frontiers in Pharmacology|January 2, 2023
ASK120067 potently suppresses B-cell or T-cell malignancies <i>in vitro</i> and <i>in vivo</i> by inhibiting BTK and ITKPeiran Song, Gang Bai, Shingpan Chan, et al.
European Journal of Medicinal Chemistry|February 16, 2018
Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancerQiuping Xiang, Chao Wang, Yan Zhang, et al.
Zoological Research|August 22, 2022
Coevolutionary insights between promoters and transcription factors in the plant and animal kingdomsJing-Song Zhang, Hai-Quan Wang, Jie Xia, et al.
European Journal of Medicinal Chemistry|May 15, 2018
Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancerXiaoqian Xue, Yan Zhang, Chao Wang, et al.
Pageof 74